Covid-19 in Ocrelizumab-treated people with Multiple Sclerosis
This article, written by the Journal of Multiple Sclerosis and related disorders, (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum. The objective was to better understand the SARS-CoV-2 infection in ocrelizumab-treated people with MS. The results show: Roche/Genentech clinical trial data: There were 51 (1.3%) […]